ArticleArchives of microbiology2026
Antibacterial mechanisms of terpinen-4-ol against Aeromonas hydrophila.
Article in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Aeromonas hydrophila (A. hydrophila) is a highly harmful pathogenic bacterium in aquaculture, and its increasingly severe drug resistance poses a threat to global aquaculture and food safety. It is an urgent need to develop new antibacterial agents. Terpinen-4-ol is a natural plant monomer with broad-spectrum antibacterial activity, but its effect and mechanism against A. hydrophila remain unclear. In this study, the minimum inhibitory concentration (MIC) of terpinen-4-ol against A. hydrophila was 7.56 mM (1.17 mg/mL), at which it effectively inhibited bacterial growth. Scanning electron microscopy (SEM) revealed morphological changes in treated A. hydrophila, including cell shrinkage, deformation, and flagellar detachment or loss. Detection of nucleic acid, protein, alkaline phosphatase (ALP), and β-galactosidase leakage, together with propidium iodide (PI) staining, showed that terpinen-4-ol caused intracellular content leakage and increased PI fluorescence intensity. Measurements of succinate dehydrogenase (SDH) activity and reactive oxygen species (ROS) levels revealed that terpinen-4-ol at 1 MIC reduced SDH activity by 55.7% and increased ROS levels by 5-fold. Crystal violet staining of biofilms further demonstrated that terpinen-4-ol at 1/2 MIC inhibited biofilm formation by 78.3%. In conclusion, terpinen-4-ol exerted its antibacterial effect on A. hydrophila by disrupting the integrity of the cell membrane and wall to cause the leakage of intracellular contents, interfering with bacterial metabolism, and inhibiting biofilm formation. This study provides potential strategies for controlling A. hydrophila infections in aquaculture and lays the foundation for future research into the antibacterial mechanism of terpinen-4-ol.
Indexed as
Identifiers
42113198What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.